Pulmonary Fibrosis Under Chemotherapy with Oxaliplatin, 5-fluorouracil, and Leucovorin

被引：0

作者：

Jung, Jin Yong ^{[1
]}

Hur, Gyu Young ^{[1
]}

Jung, Ki Hwan ^{[1
]}

Jung, Hae Chul ^{[1
]}

Lee, Sung Yong ^{[1
]}

Choi, In Keun ^{[1
]}

Lee, Sang Yeub ^{[1
]}

Kim, Je Hyeong ^{[1
]}

Seo, Jae Hong ^{[1
]}

Shin, Chol ^{[1
]}

Shim, Jae Jeong ^{[1
]}

In, Kwang Ho ^{[1
]}

Kang, Kyung Ho ^{[1
]}

Yoo, Se Hwa ^{[1
]}

机构：

[1] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea

来源：

TUBERCULOSIS AND RESPIRATORY DISEASES | 2005年 / 59卷 / 05期

关键词：

Oxaliplatin; Fluorouracil; Leucovorin; Chemotherapy; Pulmonary fibrosis;

D O I：

10.4046/trd.2005.59.5.536

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The combination of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) has recently been shown to be beneficial in advanced colorectal and gastric cancers. The side effects of this regimen include neutropenia, diarrhea and neurosensory toxicity. However, case reports on the pulmonary toxicities of this regimen are very limited. Especially, the development of pulmonary fibrosis has never been cited in the literature. Herein is reported the case of a patient treated with oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in whom pulmonary fibrosis developed, but which improved after steroid pulse therapy.

引用

页码：536 / 540

页数：5

共 50 条

[1] Pulmonary fibrosis after chemotherapy with oxaliplatin and 5-fluorouracil for colorectal cancer
Mundt, Pamela
Mochmann, Hans-Christian
Ebhardt, Harald
Zeitz, Martin
Duchmann, Rainer
Pauschinger, Matthias
ONCOLOGY, 2007, 73 (3-4) : 270 - 272
[2] Paclitaxel, oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in patients with recurrent or metastatic gastric cancer
Lan, Yan-qin
Wu, Ri-ping
Huang, Xiao-bing
Wang, Xin-li
Zhong, Dong-ta
Huang, Chuan-yong
Song, Jin-tian
TUMORI JOURNAL, 2018, 104 (01): : 22 - 29
[3] Pulmonary Toxicity with Oxaliplatin and Capecitabine/5-Fluorouracil Chemotherapy: A Case Report and Review of the Literature
Chan, Andrew K.
Choo, Bok A.
Glaholm, John
ONKOLOGIE, 2011, 34 (8-9): : 443 - 446
[4] Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX)
Muneoka, Katsuki
Shirai, Yoshio
Sasaki, Masataka
Wakai, Toshifumi
Sakata, Jun
Hatakeyama, Katsuyoshi
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) : 457 - 459
[5] 5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma
Assaf, Elias
Verlinde-Carvalho, Muriel
Delbaldo, Catherine
Grenier, Julien
Sellam, Zineb
Pouessel, Damien
Bouaita, Linda
Baumgaertner, Isabelle
Sobhani, Iradj
Tayar, Claude
Paul, Muriel
Culine, Stephane
ONCOLOGY, 2011, 80 (5-6) : 301 - 306
[6] Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) as secondline therapy for patients with advanced urothelial cancer
Zhang, Sheng
Xue, Hongxi
Chen, Qiang
ONCOTARGET, 2016, 7 (36) : 58579 - 58585
[7] Hepatic arterial infusion of oxaliplatin, 5-fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma
Melichar, B.
Ferko, A.
Krajina, A.
Rouskova, L.
Dvorak, J.
Svebisova, H.
Neoral, C.
Koecher, M.
Malirova, E.
Paral, J.
JOURNAL OF BUON, 2012, 17 (04): : 677 - 683
[8] Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
Lee, Hee Jun
Kim, Hee Seung
Park, Noh Hyun
Chung, Hyun Hoon
Kim, Jae Weon
Song, Yong Sang
CANCER RESEARCH AND TREATMENT, 2013, 45 (01): : 40 - 47
[9] An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
Caponigro, F.
Lacombe, D.
Twelves, C.
Bauer, J.
Govaerts, A. -S.
Marreaub, S.
Milano, A.
Anthoney, A.
EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 48 - 55
[10] Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-Fluorouracil/Leucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer
Yuanjue Sun Hui Zhao Yaowu Guo Feng Lin Lina Tang Yang Yao Department of Medical Oncology
Cancer Biology & Medicine, 2009, 6 (02) : 117 - 123

← 1 2 3 4 5 →